Testing effectiveness (Phase 2)Study completedNCT02570308
What this trial is testing
The Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
Who this might be right for
Uveal Melanoma
Immunocore Ltd 146
Showing 6 of 6 results